2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >= 35 kg/m(2), regardless of presence, absence, or severity of co-morbidities. MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m(2). BMI thresholds should be adjusted in the Asian population such that a BMI >= 25 kg/m(2) suggests clinical obesity, and individuals with BMI >= 27.5 kg/m(2) should be offered MBS. Long-term results of MBS consistently demonstrate safety and efficacy. Appropriately selected children and adolescents should be considered for MBS. (C) 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Automated summary

Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >= 35 kg/m(2), and should be considered for those with a metabolic disease and BMI of 30-34.9 kg/m(2). BMI thresholds should be adjusted for the Asian population, and long-term results demonstrate the safety and efficacy of MBS. Children and adolescents may also be candidates for MBS.